Rahsaan Thompson - Net Worth and Insider Trading

Rahsaan Thompson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Rahsaan Thompson owns 3 companies in total, including Gritstone Bio Inc (GRTS) , Opiant Pharmaceuticals Inc (OPNT) , and Lyell Immunopharma Inc (LYEL) .

Click here to see the complete history of Rahsaan Thompson’s form 4 insider trades.

Insider Ownership Summary of Rahsaan Thompson

Ticker	Comapny	Transaction Date	Type of Owner
GRTS	Gritstone Bio Inc	2020-04-06	EVP and General Counsel
OPNT	Opiant Pharmaceuticals Inc	2019-09-20	other: General Counsel
LYEL	Lyell Immunopharma Inc	2022-09-28	Chief Legal Officer

Rahsaan Thompson Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Rahsaan Thompson Ownership Network

Ownership Network List of Rahsaan Thompson

No Data

Ownership Network Relation of Rahsaan Thompson

Rahsaan Thompson Owned Company Details

What does Gritstone Bio Inc do?

Who are the key executives at Gritstone Bio Inc?

Rahsaan Thompson is the EVP and General Counsel of Gritstone Bio Inc. Other key executives at Gritstone Bio Inc include director & President and CEO Andrew R Allen , See Remarks Matthew Hawryluk , and See Remarks Karin Jooss .

Gritstone Bio Inc (GRTS) Insider Trades Summary

Over the past 18 months, Rahsaan Thompson made no insider transaction in Gritstone Bio Inc (GRTS). Other recent insider transactions involving Gritstone Bio Inc (GRTS) include a net sale of 1,749 shares made by Vassiliki Economides , a net sale of 24,263 shares made by Andrew R Allen , and a net sale of 13,749 shares made by Erin Jones .

In summary, during the past 3 months, insiders sold 74,769 shares of Gritstone Bio Inc (GRTS) in total and bought 0 shares, with a net sale of 74,769 shares. During the past 18 months, 74,769 shares of Gritstone Bio Inc (GRTS) were sold and 12,000 shares were bought by its insiders, resulting in a net sale of 62,769 shares.

Gritstone Bio Inc (GRTS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Gritstone Bio Inc Insider Transactions

No Available Data

What does Opiant Pharmaceuticals Inc do?

Who are the key executives at Opiant Pharmaceuticals Inc?

Rahsaan Thompson is the other: General Counsel of Opiant Pharmaceuticals Inc. Other key executives at Opiant Pharmaceuticals Inc include other: General Counsel Brian Gorman , Chief Scientific Officer Phil Skolnick , and director & 10 percent owner & Chief Executive Officer Roger Crystal .

Opiant Pharmaceuticals Inc (OPNT) Insider Trades Summary

Over the past 18 months, Rahsaan Thompson made no insider transaction in Opiant Pharmaceuticals Inc (OPNT). Other recent insider transactions involving Opiant Pharmaceuticals Inc (OPNT) include a net sale of 7,570 shares made by Roger Crystal , a net sale of 2,885 shares made by Ellison Mark Jason Heath , and a net sale of 2,556 shares made by David D O'toole .

In summary, during the past 3 months, insiders sold 0 shares of Opiant Pharmaceuticals Inc (OPNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 17,038 shares of Opiant Pharmaceuticals Inc (OPNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 17,038 shares.

Opiant Pharmaceuticals Inc (OPNT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Opiant Pharmaceuticals Inc Insider Transactions

No Available Data

What does Lyell Immunopharma Inc do?

Who are the key executives at Lyell Immunopharma Inc?

Rahsaan Thompson is the Chief Legal Officer of Lyell Immunopharma Inc. Other key executives at Lyell Immunopharma Inc include director & Executive Chairman Richard Klausner , Chief Business Officer Matthew Lang , and Chief Medical Officer Tina M. Albertson .

Lyell Immunopharma Inc (LYEL) Insider Trades Summary

Over the past 18 months, Rahsaan Thompson made no insider transaction in Lyell Immunopharma Inc (LYEL). Other recent insider transactions involving Lyell Immunopharma Inc (LYEL) include a net sale of 58,020 shares made by Richard Klausner ,

In summary, during the past 3 months, insiders sold 0 shares of Lyell Immunopharma Inc (LYEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 58,020 shares of Lyell Immunopharma Inc (LYEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 58,020 shares.

Lyell Immunopharma Inc (LYEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Lyell Immunopharma Inc Insider Transactions

No Available Data

Rahsaan Thompson Mailing Address

Above is the net worth, insider trading, and ownership report for Rahsaan Thompson. You might contact Rahsaan Thompson via mailing address: 233 Wilshire Boulevard, Suite 280, Santa Monica Ca 90401.

Discussions on Rahsaan Thompson

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.